# FDA Inspection 1061618 - HonorBridge - July 17, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/honorbridge/72115c2f-c35f-478f-be61-e65d4deb9bc9
Source feed: FDA_Inspections

> FDA Inspection 1061618 for HonorBridge on July 17, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1061618
- Company Name: HonorBridge
- Inspection Date: 2018-07-17
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1315964 - 2026-04-23](https://www.globalkeysolutions.net/records/fda_inspections/honorbridge/ce16e614-df24-414c-ab1d-4559fbac4508)
- [FDA Inspection 1191720 - 2022-10-25](https://www.globalkeysolutions.net/records/fda_inspections/honorbridge/8d4ec3f6-7df9-4f7f-94c5-3c6453b076b1)
- [FDA Inspection 1191720 - 2022-10-25](https://www.globalkeysolutions.net/records/fda_inspections/honorbridge/f1daeb76-2016-420d-92c5-0f0ee381d3fd)
- [FDA Inspection 957155 - 2016-02-03](https://www.globalkeysolutions.net/records/fda_inspections/honorbridge/ce16c2cb-7a8b-4390-8048-98d9fee1be58)
- [FDA Inspection 816355 - 2013-01-25](https://www.globalkeysolutions.net/records/fda_inspections/honorbridge/1d8ac685-5912-42b6-916e-1922ac62b195)

Company: https://www.globalkeysolutions.net/companies/honorbridge/cebdc80d-672b-4413-a182-8036399be301

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d